Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicentre study.
Soule
S
S
Conway
G
G
Hatfield
A
A
Jacobs
H
H
D000172:Acromegaly / Q000188:drug therapy*; D000208:Acute Disease; D000328:Adult; D006801:Humans; D015282:Octreotide / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced*; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000009:adverse effects*; D013004:Somatostatin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide